Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma. 2013

Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, China.

Klotho is an anti-aging protein predominantly expressed in renal tubular epithelial cells. Although Klotho was recently identified as a tumor suppressor gene in a variety of cancers, the potential role and molecular events for Klotho in renal cell carcinoma (RCC) remain obscure. In the present study, immunohistochemical staining in tissue microarrays containing 125 RCC samples showed that intratumoral Klotho levels were negatively correlated with tumor size, TNM stage and nuclear grade. The overall survival rate of RCC patients with high Klotho expression was significantly higher than that of patients with low Klotho expression. Functional analysis after gain and loss of Klotho expression revealed that Klotho blunted epithelial-mesenchymal transition and cellular migration and invasion in RCC. Also, no alteration of α-2,6-sialidase activity was found after Klotho overexpression in RCC. The molecular signals for this phenomenon involved the Klotho-mediated inhibition of PI3K/Akt/GSK3β/Snail pathway. Importantly, compared to localized RCC tissues, advanced RCC tissues exhibited low Klotho expression accompanied with high pAkt and Snail expression. These results indicate Klotho acts as a tumor suppressor by inhibiting PI3K/Akt/GSK3β/Snail signaling, thus suppressing epithelial-mesenchymal transition and tumor migration and invasion during RCC progression. As a result, Klotho might be used as a potential therapy for advanced RCC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071250 Snail Family Transcription Factors A transcription factor family characterized by the presence of several C-terminal CYS2-HIS2 ZINC FINGERS. They function in many developmental processes including the induction of the EPITHELIAL-MESENCHYMAL TRANSITION; maintenance of embryonic MESODERM; growth arrest, CELL SURVIVAL; and CELL MIGRATION. Slug Transcription Factors,Snail Transcription Factors,Transcription Factors, Slug,Transcription Factors, Snail
D000071679 Glycogen Synthase Kinase 3 beta A glycogen synthase kinase-3 type enzyme that functions in ENERGY METABOLISM; EMBRYONIC DEVELOPMENT; and NEUROGENESIS. It is also involved in PROTEIN BIOSYNTHESIS and regulates cell growth and proliferation as a component of the WNT SIGNALING PATHWAY and other signaling pathways. Certain polymorphisms in the GSK3B gene have been associated with PARKINSON DISEASE; ALZHEIMER DISEASE; and BIPOLAR DISORDER. GSK-3beta,GSK3B Protein,GSK3beta,GSK 3beta
D000090265 Klotho Proteins Membrane bound glucuronidase enzymes that may play a role in activation of FIBROBLAST GROWTH FACTORS, and in the regulation of a variety of cell signaling pathways. alpha-Klotho Proteins,beta-Klotho Proteins,alpha Klotho Proteins,beta Klotho Proteins

Related Publications

Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
August 2017, Oncology reports,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
January 2023, Medical oncology (Northwood, London, England),
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
August 2023, Aging,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
January 2020, Journal of Cancer,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
September 2019, The Laryngoscope,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
January 2024, Genes & diseases,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
January 2021, Frontiers in cell and developmental biology,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
January 2024, Medical oncology (Northwood, London, England),
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
September 2017, Experimental and therapeutic medicine,
Yu Zhu, and Le Xu, and Jianping Zhang, and Wenping Xu, and Yujun Liu, and Hankun Yin, and Tao Lv, and Huimin An, and Li Liu, and Hongyong He, and Heng Zhang, and Jing Liu, and Jiejie Xu, and Zongming Lin
October 2021, Experimental and therapeutic medicine,
Copied contents to your clipboard!